Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer

Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer

<span style="text-decoration: underline;"><i>Background</i></span>: SARS-CoV-2 mortality rates are significantly higher in patients with lung cancer compared with the general population. However, little is known on their immunization status after vaccination. <sp...

Full description

Bibliographic Details
Main Authors: Ioannis P. Trontzas, Ioannis Vathiotis, Christina Economidou, Ioulia Petridou, Georgia Gomatou, Maria Grammoustianou, Ioannis Tsamis, Nikolaos Syrigos, Maximilian Anagnostakis, Eleni Fyta, Vissaria Sakka, Garyphalia Poulakou, Elias A. Kotteas, Ekaterini Syrigou
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Vaccines
Subjects:
COVID-19
SARS-CoV-2
lung cancer
vaccination
seroconversion
humoral immunity
Online Access:https://www.mdpi.com/2076-393X/10/4/618

Internet

https://www.mdpi.com/2076-393X/10/4/618

Similar Items